Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
Tineke Casneuf,1 Amy E Axel,2 Peter King,2 John D Alvarez,2 Jillian L Werbeck,3 Tinne Verhulst,1 Karin Verstraeten,1 Brett M Hall,2 A Kate Sasser2 1Janssen Research and Development, Beerse, Belgium; 2Janssen Research and Development, Spring House, PA, 3LabConnect LLC, Seattle, WA, USAIntroduction: I...
Guardado en:
Autores principales: | Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f201d7c161d4e79a4b2094aa928728e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of the role of the interleukins in colon cancer
por: Wei,Xiyi, et al.
Publicado: (2020) -
Emerging treatments in Castleman disease – a critical appraisal of siltuximab
por: Koff JL, et al.
Publicado: (2016) -
Expression of interleukin-6 in ocular surface squamous neoplasia
por: Eghtedari M, et al.
Publicado: (2019) -
The role of interleukin-4 and interleukin-5 Th2 cytokines in assessing severity and prognosis of acute pancreatitis
por: Doklestić Krstina, et al.
Publicado: (2021) -
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts
por: Francesca Cirillo, et al.
Publicado: (2021)